324 related articles for article (PubMed ID: 31221024)
1. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin in Cardiac Tissue Repair and the Development of Diastolic Dysfunction.
Hara A; Kobayashi H; Asai N; Saito S; Higuchi T; Kato K; Okumura T; Bando YK; Takefuji M; Mizutani Y; Miyai Y; Saito S; Maruyama S; Maeda K; Ouchi N; Nagasaka A; Miyata T; Mii S; Kioka N; Worthley DL; Murohara T; Takahashi M; Enomoto A
Circ Res; 2019 Aug; 125(4):414-430. PubMed ID: 31221024
[TBL] [Abstract][Full Text] [Related]
2. A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts.
Minatoguchi S; Saito S; Furuhashi K; Sawa Y; Okazaki M; Shimamura Y; Kaihan AB; Hashimoto Y; Yasuda Y; Hara A; Mizutani Y; Ando R; Kato N; Ishimoto T; Tsuboi N; Esaki N; Matsuyama M; Shiraki Y; Kobayashi H; Asai N; Enomoto A; Maruyama S
Sci Rep; 2022 Mar; 12(1):5389. PubMed ID: 35354870
[TBL] [Abstract][Full Text] [Related]
3. Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacity.
Hara A; Kato K; Ishihara T; Kobayashi H; Asai N; Mii S; Shiraki Y; Miyai Y; Ando R; Mizutani Y; Iida T; Takefuji M; Murohara T; Takahashi M; Enomoto A
Genes Cells; 2021 Jul; 26(7):495-512. PubMed ID: 33960573
[TBL] [Abstract][Full Text] [Related]
4. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells.
Maeda K; Enomoto A; Hara A; Asai N; Kobayashi T; Horinouchi A; Maruyama S; Ishikawa Y; Nishiyama T; Kiyoi H; Kato T; Ando K; Weng L; Mii S; Asai M; Mizutani Y; Watanabe O; Hirooka Y; Goto H; Takahashi M
Sci Rep; 2016 Feb; 6():22288. PubMed ID: 26924503
[TBL] [Abstract][Full Text] [Related]
5. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
6. BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts.
Suzuki A; Sakamoto K; Nakahara Y; Enomoto A; Hino J; Ando A; Inoue M; Shiraki Y; Omote N; Kusaka M; Fukihara J; Hashimoto N
Am J Respir Cell Mol Biol; 2022 Oct; 67(4):446-458. PubMed ID: 35728045
[TBL] [Abstract][Full Text] [Related]
7. Meflin is a marker of pancreatic stellate cells involved in fibrosis and epithelial regeneration in the pancreas.
Ando R; Shiraki Y; Miyai Y; Shimizu H; Furuhashi K; Minatoguchi S; Kato K; Kato A; Iida T; Mizutani Y; Ito K; Asai N; Mii S; Esaki N; Takahashi M; Enomoto A
J Pathol; 2024 Jan; 262(1):61-75. PubMed ID: 37796386
[TBL] [Abstract][Full Text] [Related]
8. Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis.
Takahashi M; Kobayashi H; Mizutani Y; Hara A; Iida T; Miyai Y; Asai N; Enomoto A
Front Cell Dev Biol; 2021; 9():749924. PubMed ID: 34676218
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue.
Kuwano T; Izumi H; Aslam MR; Igarashi Y; Bilal M; Nishimura A; Watanabe Y; Nawaz A; Kado T; Ikuta K; Yamamoto S; Sasahara M; Fujisaka S; Yagi K; Mori H; Tobe K
PLoS One; 2021; 16(3):e0248267. PubMed ID: 33760832
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin.
Chen P; Wu R; Zhu W; Jiang Z; Xu Y; Chen H; Zhang Z; Chen H; Zhang L; Yu H; Wang J; Hu X
PLoS One; 2014; 9(8):e103587. PubMed ID: 25116394
[TBL] [Abstract][Full Text] [Related]
12. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
[TBL] [Abstract][Full Text] [Related]
13. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
Yang R; Song Z; Wu S; Wei Z; Xu Y; Shen X
Atherosclerosis; 2018 Dec; 279():23-31. PubMed ID: 30399463
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.
Mias C; Lairez O; Trouche E; Roncalli J; Calise D; Seguelas MH; Ordener C; Piercecchi-Marti MD; Auge N; Salvayre AN; Bourin P; Parini A; Cussac D
Stem Cells; 2009 Nov; 27(11):2734-43. PubMed ID: 19591227
[TBL] [Abstract][Full Text] [Related]
16. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
17. Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis.
Wu J; Subbaiah KCV; Xie LH; Jiang F; Khor ES; Mickelsen D; Myers JR; Tang WHW; Yao P
Circ Res; 2020 Aug; 127(6):827-846. PubMed ID: 32611237
[TBL] [Abstract][Full Text] [Related]
18. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis.
Nakahara Y; Hashimoto N; Sakamoto K; Enomoto A; Adams TS; Yokoi T; Omote N; Poli S; Ando A; Wakahara K; Suzuki A; Inoue M; Hara A; Mizutani Y; Imaizumi K; Kawabe T; Rosas IO; Takahashi M; Kaminski N; Hasegawa Y
Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34049947
[TBL] [Abstract][Full Text] [Related]
20. The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation.
Chavkin NW; Sano S; Wang Y; Oshima K; Ogawa H; Horitani K; Sano M; MacLauchlan S; Nelson A; Setia K; Vippa T; Watanabe Y; Saucerman JJ; Hirschi KK; Gokce N; Walsh K
J Am Heart Assoc; 2021 Jul; 10(13):e019904. PubMed ID: 34155901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
